These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 17473186)

  • 1. Expression of a peroxisome proliferator-activated receptor gamma 1 splice variant that was identified in human lung cancers suppresses cell death induced by cisplatin and oxidative stress.
    Kim HJ; Hwang JY; Kim HJ; Choi WS; Lee JH; Kim HJ; Chang KC; Nishinaka T; Yabe-Nishimura C; Seo HG
    Clin Cancer Res; 2007 May; 13(9):2577-83. PubMed ID: 17473186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential peroxisome proliferator-activated receptor-gamma isoform expression and agonist effects in normal and malignant prostate cells.
    Subbarayan V; Sabichi AL; Kim J; Llansa N; Logothetis CJ; Lippman SM; Menter DG
    Cancer Epidemiol Biomarkers Prev; 2004 Nov; 13(11 Pt 1):1710-6. PubMed ID: 15533897
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relationship between peroxisome proliferator-activated receptor-gamma expression and differentiation of human esophageal squamous cell carcinoma.
    Takashima T; Fujiwara Y; Hamaguchi M; Sasaki E; Tominaga K; Watanabe T; Oshitani N; Higuchi K; Arakawa T
    Oncol Rep; 2005 Apr; 13(4):601-6. PubMed ID: 15756430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a truncated alternative splicing variant of human PPARgamma1 that exhibits dominant negative activity.
    Kim HJ; Woo IS; Kang ES; Eun SY; Kim HJ; Lee JH; Chang KC; Kim JH; Seo HG
    Biochem Biophys Res Commun; 2006 Sep; 347(3):698-706. PubMed ID: 16842753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC).
    Bren-Mattison Y; Van Putten V; Chan D; Winn R; Geraci MW; Nemenoff RA
    Oncogene; 2005 Feb; 24(8):1412-22. PubMed ID: 15608671
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activation of peroxisome proliferator-activated receptor-gamma by troglitazone (TGZ) inhibits human lung cell growth.
    Li M; Lee TW; Mok TS; Warner TD; Yim AP; Chen GG
    J Cell Biochem; 2005 Nov; 96(4):760-74. PubMed ID: 16149072
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apoptotic action of peroxisome proliferator-activated receptor-gamma activation in human non small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation.
    Kim KY; Ahn JH; Cheon HG
    Mol Pharmacol; 2007 Sep; 72(3):674-85. PubMed ID: 17535976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MKP1/CL100 controls tumor growth and sensitivity to cisplatin in non-small-cell lung cancer.
    Chattopadhyay S; Machado-Pinilla R; Manguan-García C; Belda-Iniesta C; Moratilla C; Cejas P; Fresno-Vara JA; de Castro-Carpeño J; Casado E; Nistal M; Gonzalez-Barón M; Perona R
    Oncogene; 2006 Jun; 25(23):3335-45. PubMed ID: 16462770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-gamma downregulates Hsp27 expression and suppresses the negative regulation of cell death in oral squamous cell carcinoma lines.
    Yonekura N; Yokota S; Yonekura K; Dehari H; Arata S; Kohama G; Fujii N
    Cell Death Differ; 2003 Mar; 10(3):313-22. PubMed ID: 12700631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of peroxisome proliferator-activated receptor (PPAR)-gamma in human lung cancer.
    Inoue K; Kawahito Y; Tsubouchi Y; Yamada R; Kohno M; Hosokawa Y; Katoh D; Bishop-Bailey D; Hla T; Sano H
    Anticancer Res; 2001; 21(4A):2471-6. PubMed ID: 11724309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of targeting protein for xklp2 associated with both malignant transformation of respiratory epithelium and progression of squamous cell lung cancer.
    Ma Y; Lin D; Sun W; Xiao T; Yuan J; Han N; Guo S; Feng X; Su K; Mao Y; Cheng S; Gao Y
    Clin Cancer Res; 2006 Feb; 12(4):1121-7. PubMed ID: 16489064
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor-gamma and growth inhibition by its ligands in prostate cancer.
    Nagata D; Yoshihiro H; Nakanishi M; Naruyama H; Okada S; Ando R; Tozawa K; Kohri K
    Cancer Detect Prev; 2008; 32(3):259-66. PubMed ID: 18789607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. PPAR gamma protects cardiomyocytes against oxidative stress and apoptosis via Bcl-2 upregulation.
    Ren Y; Sun C; Sun Y; Tan H; Wu Y; Cui B; Wu Z
    Vascul Pharmacol; 2009; 51(2-3):169-74. PubMed ID: 19540934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of the peroxisome proliferator-activated receptors-alpha, -beta, and -gamma in ovarian carcinoma effusions is associated with poor chemoresponse and shorter survival.
    Davidson B; Hadar R; Stavnes HT; Trope' CG; Reich R
    Hum Pathol; 2009 May; 40(5):705-13. PubMed ID: 19157507
    [TBL] [Abstract][Full Text] [Related]  

  • 15. c-Myc-induced chemosensitization is mediated by suppression of cyclin D1 expression and nuclear factor-kappa B activity in pancreatic cancer cells.
    Biliran H; Banerjee S; Thakur A; Sarkar FH; Bollig A; Ahmed F; Wu J; Sun Y; Liao JD
    Clin Cancer Res; 2007 May; 13(9):2811-21. PubMed ID: 17473215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for differential effects of glucose and cycloheximide on mRNA levels of peroxisome proliferator-activated receptor- (PPAR-) machinery members: Superinduction of PPAR-gamma1 and -gamma2 mRNAs.
    Rypka M; Veselý J
    Acta Biochim Pol; 2010; 57(2):209-15. PubMed ID: 20563322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiapoptotic activity of autocrine interleukin-22 and therapeutic effects of interleukin-22-small interfering RNA on human lung cancer xenografts.
    Zhang W; Chen Y; Wei H; Zheng C; Sun R; Zhang J; Tian Z
    Clin Cancer Res; 2008 Oct; 14(20):6432-9. PubMed ID: 18927282
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity.
    Zhang Y; Shen X
    Clin Cancer Res; 2007 May; 13(10):2855-64. PubMed ID: 17504983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect and mechanism of peroxisome proliferator-activated receptor-γ on the drug resistance of the U-87 MG/CDDP human malignant glioma cell line.
    Han S; Lv X; Wang Y; Gong H; Zhang C; Tong A; Zhang B; Yao H
    Mol Med Rep; 2015 Aug; 12(2):2239-46. PubMed ID: 25891367
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and physiological functions of the human peroxisome proliferator-activated receptor gamma.
    Zieleniak A; Wójcik M; Woźniak LA
    Arch Immunol Ther Exp (Warsz); 2008; 56(5):331-45. PubMed ID: 18836859
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.